Search research articles
Contact Us
Filters
Showing results (151-160 of 1,622) with videos related to
Page
of 163
Sort By:
Gynecologic Oncology
|
July 29, 2011
Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer
Maurie Markman
Cancer
|
March 27, 2007
The dangers of "cross-trial" and "cross-retrospective experience" comparisons: examples employing data in the peer-reviewed ovarian cancer literature
Maurie Markman
Journal of Women'S Health (2002)
|
November 16, 2007
HPV vaccination and the prevention of cervical cancer: the long road ahead
Maurie Markman
Current Oncology Reports
|
June 26, 2007
Mentoring in the ethics of clinical research: an ongoing need
Maurie Markman
Gynecologic Oncology
|
June 15, 1999
Concerns with "maintenance chemotherapy" for patients with recurrent platinum-sensitive ovarian cancer
M Markman
Gynecologic Oncology
|
August 6, 2000
Limits to the "benefits" from our oncologic interventions: a case report
M Markman
Cancer Investigation
|
December 7, 2007
"Of models and men (or women)"--a brief story of a mathematical model and its influence on the management of ovarian cancer
Maurie Markman
Cancer Investigation
|
January 9, 2008
Objective data rather than opinion in the interpretation of the legitimate goals of phase 1 oncology trials
Maurie Markman
Oncology
|
January 12, 2008
Are we entering the era of maintenance therapy of advanced malignant disease?
Maurie Markman
Cancer Investigation
|
January 1, 1995
Is there a role for intraperitoneal therapy in the management of gastrointestinal malignancies?
M Markman
Page
of 163
Search research articles
Search
Showing results (151-160 of 1,622) with videos related to
Sort By:
Page
of 163
Gynecologic Oncology
|
July 29, 2011
Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer
Maurie Markman
Cancer
|
March 27, 2007
The dangers of "cross-trial" and "cross-retrospective experience" comparisons: examples employing data in the peer-reviewed ovarian cancer literature
Maurie Markman
Journal of Women'S Health (2002)
|
November 16, 2007
HPV vaccination and the prevention of cervical cancer: the long road ahead
Maurie Markman
Current Oncology Reports
|
June 26, 2007
Mentoring in the ethics of clinical research: an ongoing need
Maurie Markman
Gynecologic Oncology
|
June 15, 1999
Concerns with "maintenance chemotherapy" for patients with recurrent platinum-sensitive ovarian cancer
M Markman
Gynecologic Oncology
|
August 6, 2000
Limits to the "benefits" from our oncologic interventions: a case report
M Markman
Cancer Investigation
|
December 7, 2007
"Of models and men (or women)"--a brief story of a mathematical model and its influence on the management of ovarian cancer
Maurie Markman
Cancer Investigation
|
January 9, 2008
Objective data rather than opinion in the interpretation of the legitimate goals of phase 1 oncology trials
Maurie Markman
Oncology
|
January 12, 2008
Are we entering the era of maintenance therapy of advanced malignant disease?
Maurie Markman
Cancer Investigation
|
January 1, 1995
Is there a role for intraperitoneal therapy in the management of gastrointestinal malignancies?
M Markman
Page
of 163